Table 2 Follow-up data

mRECIST

0.437^a

 CR

13 (46%)

15 (65%)

 PR

10 (36%)

5 (22%)

 SD

5 (18%)

3 (13%)

 PD

0

0

 ORR

23 (82%)

19 (83%)

 DCR

28 (100%)

22 (100%)

Child–Pugh class

0.764^b

 A

20 (71%)

15 (65%)

 B

8 (29%)

8 (35%)

AFP level

5.2 (3.1–14.2)

4.9 (2.5–16.1)

0.011

Adverse Events

0.411^a

 Liver dysfunction

3 (11%)

1 (4%)

0.617^a

 Pleural effusion

1 (4%)

0

0.193^a

 Spontaneous bacterial peritonitis

2 (7%)

4 (17%)

0.390^a

 Gastrointestinal hemorrhage

0

0

n.d

 liver abscess

5 (18%)

8 (35%)

0.207^a

 Pulmonary/cerebraloil embolization

0

0

n.d